Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Current Assets (2019 - 2025)

Korro Bio's Current Assets history spans 7 years, with the latest figure at $82.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 37.37% year-over-year to $82.4 million, compared with a TTM value of $82.4 million through Dec 2025, down 37.37%, and an annual FY2025 reading of $82.4 million, down 37.37% over the prior year.
  • Current Assets for Q4 2025 was $82.4 million at Korro Bio, down from $98.2 million in the prior quarter.
  • The five-year high for Current Assets was $200.1 million in Q1 2021, with the low at $42.5 million in Q3 2023.
  • Average Current Assets over 5 years is $119.0 million, with a median of $120.6 million recorded in 2022.
  • Year-over-year, Current Assets tumbled 57.92% in 2023 and then surged 259.49% in 2024.
  • Tracing KRRO's Current Assets over 5 years: stood at $134.7 million in 2021, then plummeted by 57.64% to $57.1 million in 2022, then soared by 202.59% to $172.7 million in 2023, then dropped by 23.85% to $131.5 million in 2024, then plummeted by 37.37% to $82.4 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Current Assets are $82.4 million (Q4 2025), $98.2 million (Q3 2025), and $102.6 million (Q2 2025).